The UK government project has signed a contrdact with Shanghai Biotechnology Co. to join in models and tumor control paired analysis reporting tools, helping to more efficiently resolve genomic data and rapid identification causative mutation rare diseases and cancer driven mutation. This is expected to enhance the quality of genomic data interpretation, the researchers deepen understanding of the disease and to develop more targeted treatment programs.

CAS news release, November 16, 2015